e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Comorbidities and respiratory disease and late-breaking abstracts
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic inflammatory airway disorders and lower limb arterial disease (LLAD)
G. Pesce, M. Ferrari, A. Marcon, P. Vallerio, R. de Marco (Verona, Italy)
Source:
Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Session:
Comorbidities and respiratory disease and late-breaking abstracts
Session type:
Poster Discussion
Number:
3439
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Pesce, M. Ferrari, A. Marcon, P. Vallerio, R. de Marco (Verona, Italy). Chronic inflammatory airway disorders and lower limb arterial disease (LLAD). Eur Respir J 2013; 42: Suppl. 57, 3439
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Obesity and impairments in chronic obstruction pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Systemic inflammation, comorbidities and the outcome of adult-onset asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Asthma in the elderly
Source: Eur Respir Mon; 2009: 43: 56–76
Year: 2009
Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Venous thromboembolic disease (VTD) associated with inflammatory bowel disease (IBD): RIETE´s experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Endothelial dysfunction and arterial rigidity in patients with bronchial asthma out of an exacerbation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Fixed airway obstruction in severe asthma
Source: Eur Respir Mon 2011; 51: 147-159
Year: 2011
The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Factors associated with irreversible airway obstruction in patients with asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Chronic obstructive pulmonary disease (COPD) exacerbations and carotid artery plaques: The Rotterdam study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
The comorbid patients with arterial hypertension and chronic obstructive pulmonary disease: Assessment of diastolic wall strain
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA)
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept